273 related articles for article (PubMed ID: 19641369)
21. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
[TBL] [Abstract][Full Text] [Related]
22. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
23. DNA-methylation analysis identifies the E-cadherin gene as a potential marker of disease progression in patients with monoclonal gammopathies.
Seidl S; Ackermann J; Kaufmann H; Keck A; Nösslinger T; Zielinski CC; Drach J; Zöchbauer-Müller S
Cancer; 2004 Jun; 100(12):2598-606. PubMed ID: 15197802
[TBL] [Abstract][Full Text] [Related]
24. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
25. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3.
Tan SH; Ida H; Lau QC; Goh BC; Chieng WS; Loh M; Ito Y
Oncol Rep; 2007 Nov; 18(5):1225-30. PubMed ID: 17914577
[TBL] [Abstract][Full Text] [Related]
26. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of the CpG island of connexin 32, a candiate tumor suppressor gene in renal cell carcinomas from hemodialysis patients.
Yano T; Ito F; Kobayashi K; Yonezawa Y; Suzuki K; Asano R; Hagiwara K; Nakazawa H; Toma H; Yamasaki H
Cancer Lett; 2004 May; 208(2):137-42. PubMed ID: 15142671
[TBL] [Abstract][Full Text] [Related]
28. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
29. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation status of multiple genes in uveal melanoma.
Merhavi E; Cohen Y; Avraham BC; Frenkel S; Chowers I; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4403-6. PubMed ID: 17898258
[TBL] [Abstract][Full Text] [Related]
32. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
Derks S; Postma C; Carvalho B; van den Bosch SM; Moerkerk PT; Herman JG; Weijenberg MP; de Bruïne AP; Meijer GA; van Engeland M
Carcinogenesis; 2008 Feb; 29(2):434-9. PubMed ID: 18048385
[TBL] [Abstract][Full Text] [Related]
33. Genetic and epigenetic control of UNC5C expression in human renal cell carcinoma.
Lv D; Zhao W; Dong D; Qian XP; Zhang Y; Tian XJ; Zhang J
Eur J Cancer; 2011 Sep; 47(13):2068-76. PubMed ID: 21600761
[TBL] [Abstract][Full Text] [Related]
34. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.
Cho M; Uemura H; Kim SC; Kawada Y; Yoshida K; Hirao Y; Konishi N; Saga S; Yoshikawa K
Br J Cancer; 2001 Aug; 85(4):563-7. PubMed ID: 11506497
[TBL] [Abstract][Full Text] [Related]
35. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer.
Jarmalaite S; Jankevicius F; Kurgonaite K; Suziedelis K; Mutanen P; Husgafvel-Pursiainen K
Oncology; 2008; 75(3-4):145-51. PubMed ID: 18824877
[TBL] [Abstract][Full Text] [Related]
37. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O
Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525
[TBL] [Abstract][Full Text] [Related]
38. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study.
Hauser S; Zahalka T; Fechner G; Müller SC; Ellinger J
Anticancer Res; 2013 Oct; 33(10):4651-6. PubMed ID: 24123044
[TBL] [Abstract][Full Text] [Related]
39. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
40. Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma.
Zhang Q; Ying J; Zhang K; Li H; Ng KM; Zhao Y; He Q; Yang X; Xin D; Liao SK; Tao Q; Jin J
Cancer Lett; 2007 May; 249(2):220-6. PubMed ID: 17029774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
